Sunday, July 1, 2012

Study and make the new development in cancer treatment of

Study and make the new development in cancer treatment of prostate
American researcher find, ease pain antiinflammatory agent a and a lower cholesterol medicine, combine together and use recently according to the report of Washington (Xinhua) the 15th April, can produce obvious curative effect to prostate cancer. Researchers say, this discovery has opened up the new thinking in order to treat prostate cancer.

New Jersey, Rutgers of American, set up university, say, have, study, reveal already before this a few days ago, the antalgesic Western music of American Pfizer is retained and lowered cholesterol medicines and stood generally properly during each single application, can grow and exert a sure influence to the cancer cell separately. The researchers of this school's new result of study shows, combine two kinds of medicines together the experiment mouse with prostate cancer treats, can inhibit the growth of the cancer cell effectively.

R in early days, needs relying on androgen, so often adopt and inhibit methods such as androgenic production,etc. from treating early prostate cancer i at prostate cancer at present in growth of the cancer cell. Though similar therapeutic method has certain results, it is not the dependence that will often cause the cancer cell to produce androgen, thus make it lose the result not to treat, and will make the aggressiveness of the cancer cell strengthen.

Researchers say, the new result of study reveals, two kinds of medicines jointly use and can inhibit the cancer cell of prostate from growing more effectively, delay its producing process that androgen is not dependence greatly. This will bring the thinking different from the past for looking for new treatment of prostate cancer. They analyze, two kinds of medicines jointly use a signal passway that may have inhibited the cancer cell, have inhibited the growth of the cancer cell finally.



Study and make the new development in cancer treatment of prostate

No comments:

Post a Comment